Most people with acute valley fever don't require treatment. Even when symptoms are severe, the best therapy for otherwise healthy adults is often bed rest and fluids — the same approach used for colds and the flu. Still, doctors carefully monitor people with valley fever.
If symptoms don't improve or become worse or if you are at increased risk of complications, your doctor may prescribe an antifungal medication, such as fluconazole. Antifungal medications are also used for people with chronic or disseminated disease.
In general, the antifungal drugs fluconazole (Diflucan) or itraconazole (Sporanox, Onmel) are used for all but the most serious forms of coccidioidomycosis disease.
All antifungals can have serious side effects. However, these side effects usually go away once the medication is stopped. Possible side effects of fluconazole and itraconazole are nausea, vomiting, abdominal pain and diarrhea.
More serious infection may be treated initially with an intravenous antifungal medication such as amphotericin B (Abelcet, Amphotec, others).
Two newer medications — voriconazole and posaconazole (Noxafil) — may also be used to treat more serious infections.
Antifungals control the fungus, but sometimes don't destroy it, and relapses may occur. For many people, a single bout of valley fever results in lifelong immunity, but the disease can be reactivated, or you can be reinfected if your immune system is significantly weakened.
May 27, 2015
- Ferri FF. Coccidioidomycosis. In: Ferri's Clinical Advisor 2015: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2015. https://www.clinicalkey.com. Accessed April 23, 2015.
- Nimmer N, et al. Coccidioidomycosis. Pediatrics in Review. 2015;36:181.
- Nguyen C, et al. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clinical Microbiology Reviews. 2013;26:505.
- Wilken JA, et al. Coccidioidomycosis Among Cast and Crew Members at an Outdoor Television Filming Event — California, 2012. MMWR. 2014;63:321.
- Galgiani JN, et al. Primary coccidioidal infection. http://www.uptodate.com/home. Accessed April 23, 2015.
- Longo DL, et al. Coccidioidomycosis. In: Harrison's Principles of Internal Medicine. 18th ed. New York, N.Y.: The McGraw-Hill Companies; 2012. http://www.accessmedicine.com. Accessed April 23, 2015.
- Coccidioidomycosis. Centers for Disease Control and Prevention. http://www.cdc.gov/fungal/diseases/coccidioidomycosis/index.html. Accessed April 23, 2015.
- Papadakis MA, et al., eds. Mycotic infections. In: Current Medical Diagnosis & Treatment 2014. 54th ed. New York, N.Y.: The McGraw-Hill Companies; 2015. http://www.accessmedicine.com. Accessed April 23, 2015.
- Coccidioidomycosis (Valley fever) — Jobs at risk. Centers for Disease Control and Prevention. http://www.cdc.gov/niosh/topics/valleyfever/risk.html. Accessed April 30, 2015.
- Bennett JE, et al. Coccidioidomycosis. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2010. https://www.clinicalkey.com. Accessed April 23, 2015.